FDA: Pancreatic enzyme drugmakers must submit NDA

NSAIDS are typically the first line of treatment for axial spondyloarthritis.

Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.

Chronic pain is more prevalent—and more severe—in veterans compared with the general US population.

Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.

Research presented at American Heart Association’s 2024 Scientific Sessions examined the SGLT inhibitor’s effect on systolic blood pressure.

Investigators evaluated the role that cannabis plays in pain management in different populations with rheumatic diseases.